
Evolva’s revenues up 25%, shifting product focuses to stevia, nootkatone, and resveratrol
In Switzerland, Evolva announced positive 2015 financial results, with revenues up 25% to CHF 13.4 million and manufacturing efficiency for launched products improving by c. 50% in the last 18 months. The company intends to focus on three highly profitable products in the near term: stevia, nootkatone, and resveratrol. After its launch of both its […]